Status:
COMPLETED
Targeting Taboo Thoughts In Obsessive-Compulsive Disorder
Lead Sponsor:
Karolinska Institutet
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this pilot study is to investigate if a cognitive treatment targeting obsessive beliefs in patients with aggressive obsessions is feasible and effective as an online treatment.
Detailed Description
Patients with obsessive-compulsive disorder who presents with aggressive obsessions (also known as taboo thoughts e.g. fear of being a pedophile) and mental rituals have shown to respond less well to ...
Eligibility Criteria
Inclusion
- Diagnosis of OCD taboo thoughts as specified in the DSM-5
- ≥ 18 years
- Situated in Sweden
- Informed consent
Exclusion
- No signed consent
- Not fluent speaking in Swedish or cognitive abilities to read written material in the study
- Adjusted pharmacological treatment the last month symptoms that may affect OCD symptoms
- Substance dependence during the last six months
- Psychosis
- Ongoing mania or hypomania
- Suicidal risk that may affect study participation
- Personality disorder that may significantly affect the treatment participation
- Other ongoing psychological treatments that may affect OCD-symptoms
- Other primary psychiatric diagnosis
Key Trial Info
Start Date :
March 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04313439
Start Date
March 26 2020
End Date
August 11 2021
Last Update
August 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Sweden, 17177